Introduced
Underlined text would be added to current law. Struck-through text would be removed.
| 89R4932 DNC-F | ||
| By: Menéndez | S.B. No. 563 |
| A BILL TO BE ENTITLED | |
| AN ACT | |
| relating to health benefit plan coverage for treatment of autism | |
| spectrum disorders. | |
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| SECTION 1. Section 1355.001(3), Insurance Code, is amended | |
| to read as follows: | |
| (3) "Autism spectrum disorder" means: | |
| (A) a neurobiological disorder that | |
| significantly affects verbal communication, nonverbal | |
| communication, and social interaction and that meets the diagnostic | |
| criteria for autism spectrum disorder specified by the Diagnostic | |
| and Statistical Manual of Mental Disorders, 5th edition, or a later | |
| edition; or | |
| (B) a diagnosis made using a previous edition of | |
| the Diagnostic and Statistical Manual of Mental Disorders of | |
| [ |
|
| Disorder--Not Otherwise Specified. | |
| SECTION 2. Section 1355.015, Insurance Code, is amended by | |
| amending Subsections (a-1) and (c) and adding Subsections (a-2) and | |
| (c-2) to read as follows: | |
| (a-1) At a minimum, a health benefit plan must provide | |
| coverage for any medically necessary treatment of autism spectrum | |
| disorder as provided by this section to an enrollee who is diagnosed | |
| with autism spectrum disorder from the date of diagnosis[ |
|
| (a-2) For purposes of Subsection (a-1): | |
| (1) "Medically necessary" means a service or product | |
| that: | |
| (A) addresses the specific needs of a patient; | |
| (B) is provided for the purpose of: | |
| (i) screening for, preventing, diagnosing, | |
| managing, or treating an illness, injury, or condition, or the | |
| symptoms of that illness, injury, or condition, including by | |
| minimizing the progress of an illness, injury, or condition; or | |
| (ii) preventing regression or ensuring | |
| maintenance of skills; | |
| (C) is delivered in accordance with the generally | |
| recognized independent standards of mental health and substance use | |
| disorder care; | |
| (D) is clinically appropriate in terms of type | |
| for the service or product; and | |
| (E) is not provided primarily for: | |
| (i) the economic benefit of the health | |
| benefit plan issuer or person who purchases the service or product; | |
| or | |
| (ii) the convenience of the patient, | |
| treating physician, or other health care provider. | |
| (2) "Generally recognized independent standards of | |
| mental health and substance use disorder care" means a standard of | |
| care and clinical practice that: | |
| (A) is generally recognized by health care | |
| providers practicing in the applicable clinical specialty, | |
| including in psychiatry, psychology, clinical sociology, addiction | |
| medicine, counseling, applied behavioral analysis, or behavioral | |
| health treatment; and | |
| (B) is based on valid, evidence-based sources | |
| reflecting generally accepted standards of mental health and | |
| substance use disorder care, including: | |
| (i) peer-reviewed scientific studies or | |
| medical literature; and | |
| (ii) the recommendation of a governmental | |
| agency or relevant nonprofit health care provider professional | |
| trade association or specialty society, including: | |
| (a) patient placement criteria | |
| promulgated by the National Library of Medicine; | |
| (b) clinical practice guidelines | |
| promulgated by the National Center for Complementary and | |
| Integrative Health; | |
| (c) the recommendation of a federal | |
| governmental agency; | |
| (d) drug labeling approved by the | |
| United States Food and Drug Administration; and | |
| (e) clinical practice guidelines, | |
| developed and promulgated by the Council of Autism Service | |
| Providers, for the treatment of autism spectrum disorder. | |
| (c) For purposes of Subsections [ |
|
| "generally recognized services" may include services such as: | |
| (1) evaluation and assessment services; | |
| (2) applied behavior analysis; | |
| (3) behavior training and behavior management; | |
| (4) speech therapy; | |
| (5) occupational therapy; | |
| (6) physical therapy; or | |
| (7) medications or nutritional supplements used to | |
| address symptoms of autism spectrum disorder. | |
| (c-2) The health benefit plan may not: | |
| (1) prohibit or place a limitation on a health care | |
| practitioner described by Subsection (b)(1) from performing an | |
| evaluation or reevaluation, or soliciting a confirmation of | |
| diagnosis of autism spectrum disorder from a primary care physician | |
| or a diagnostician who has previously provided a diagnosis of | |
| autism spectrum disorder for an enrollee; or | |
| (2) restrict the setting in which generally recognized | |
| services prescribed in relation to autism spectrum disorder are | |
| provided to the enrollee, including assessments, evaluation, | |
| therapeutic intervention, or observations, except for a setting in | |
| which the enrollee qualifies for reimbursable services under the | |
| state Medicaid program, including under the school health and | |
| related services program. | |
| SECTION 3. Section 1355.015(c-1), Insurance Code, is | |
| repealed. | |
| SECTION 4. The changes in law made by this Act apply only to | |
| a health benefit plan delivered, issued for delivery, or renewed on | |
| or after January 1, 2026. A health benefit plan delivered, issued | |
| for delivery, or renewed before January 1, 2026, is governed by the | |
| law as it existed immediately before the effective date of this Act, | |
| and that law is continued in effect for that purpose. | |
| SECTION 5. This Act takes effect September 1, 2025. |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.